View in EDS HTML Full Text PDF Full Text

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.
Authors: Anobile, Dario Pasquale1,2 (AUTHOR), Barbar, Layla1 (AUTHOR), Maucotel, Emile1 (AUTHOR), Cornec, Alexis1 (AUTHOR), Manriquez, Valeria2,3 (AUTHOR), Richer, Wilfrid2,3 (AUTHOR), Denizeau, Jordan2,3 (AUTHOR), Sedlik, Christine2,3 (AUTHOR), Bories, Charlie1 (AUTHOR), Couderc, Elodie1 (AUTHOR), Leclere, Renaud4 (AUTHOR), Sobas, Judith4 (AUTHOR), Papillon, Emeline5 (AUTHOR), Mena Osuna, Rafael2,3 (AUTHOR), Tosello-Boari, Jimena2,3 (AUTHOR), Burbage, Marianne5 (AUTHOR), Piaggio, Eliane2,3 (AUTHOR) eliane.piaggio@curie.fr, Poirier, Enzo Z.1 (AUTHOR) eliane.piaggio@curie.fr
Source: PLoS Biology. 6/18/2026, Vol. 24 Issue 6, p1-21. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15449173
DOI:10.1371/journal.pbio.3003860